new glp-1 medications for Weight Loss New research is taking a
Description
Barale C, et al
With skyrocketing demand for semaglutide and tirzepatide (popularized under brand names Ozempic, Wegovy, Zepbound, and Mounjaro), the stage was set for a compounding boom

Beyond weight loss, GLP-1 receptors exist in the ovaries and brain, potentially reducing PCOS-related hyperinsulinemia and supporting ovulation

The pharmacologic effects of GLP-1 are noted in the next figure
Other side effects to monitor Patients switching between formulations should also be aware of potential headaches associated with GLP-1 therapy , tirzepatide body aches , muscle pain , insomnia , and semaglutide-related sleep disruption
